Product Information
MUCUS RELIEF D ER 1,200-120 MG is a generic product labeled by Cardinal Health, priced at $0.4235 per EA under NDC 70000071901. Its NADAC has been published 33 times since Feb 18, 2026.
FDA first approved this application on Feb 1, 2022.
Strength
1200; 120 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000071901
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214407FDA Approved
2/1/2022
On Market Since
3/8/2025
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RELIEF D ER 1,200-120 MG has been published 33 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4235 per EA |
|---|---|
| All-time high | $0.4235 (Sep 30, 2026) |
| All-time low | $0.4177 (Feb 18, 2026) |
| 52-week high | $0.4235 |
| 52-week low | $0.4177 |
| Median price | $0.4198 |
| Average price | $0.4204 |
| Largest weekly change | +0.3% (Jul 22, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
guaifenesin, pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RELIEF D ER 1,200-120 MG?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RELIEF D ER 1,200-120 MG, manufactured by Cardinal Health, is $0.4235 per EA (NDC 70000071901), effective Sep 30, 2026.
How has the price of MUCUS RELIEF D ER 1,200-120 MG changed over time?
Over the history we have for it, the NADAC for MUCUS RELIEF D ER 1,200-120 MG has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for MUCUS RELIEF D ER 1,200-120 MG?
Since Feb 18, 2026, the NADAC for MUCUS RELIEF D ER 1,200-120 MG has ranged from a low of $0.4177 (Feb 18, 2026) to a high of $0.4235 (Sep 30, 2026), with a median of $0.4198 per EA.
Are there cheaper alternatives to MUCUS RELIEF D ER 1,200-120 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MUCUS RELIEF D ER 1,200-120 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCUS RELIEF D ER 1,200-120 MG?
MUCUS RELIEF D ER 1,200-120 MG (NDC 70000071901) is labeled by Cardinal Health, and CMS classifies it as a generic product.